Sign In
Buy ELV
$388.50
-2.77 (-0.708%)
At Close: Jun 18, 2026
Elevance Tops $1B in Housing Investments: What's Driving the Strategy?
01:46pm, Thursday, 18'th Jun 2026
ELV surpasses $1B in affordable housing investments, aiming to improve health outcomes, expand care access and support long-term growth.
The Healthcare M&A Wave
12:30pm, Wednesday, 17'th Jun 2026
In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) today announced it has invested $640 million in affordable housing over the past five years, building on more than $1 billion invested over n
ELV DCF Analysis: Intrinsic Value $643 vs Price $402
07:27am, Tuesday, 16'th Jun 2026
On June 16, 2026, we present a discounted cash flow (DCF) analysis for Elevance Health Inc (ELV). The stock has shown a price performance of -3.5% over the past
Invesco's RSPH vs. PJP: Which Health Care ETF Is the Better Fund For The GLP-1 Revolution?
04:42pm, Monday, 15'th Jun 2026
Compare portfolio strategies, cost structures, and risk profiles as two Invesco healthcare ETFs take different paths to sector exposure.
Elevance Health Makes Chronic Care Easier to Navigate With Connected, Personalized Support
10:00am, Monday, 15'th Jun 2026
INDIANAPOLIS--(BUSINESS WIRE)--Across the country, three in four adults are living with at least one chronic condition. Elevance Health is helping people manage chronic conditions by creating more per
Elevance Health, Inc. (ELV) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
08:22am, Thursday, 11'th Jun 2026
Elevance Health, Inc. (ELV) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Dividend Champion, Contender, And Challenger Highlights: Week Of June 7
06:19pm, Friday, 05'th Jun 2026
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade)
09:35am, Monday, 01'st Jun 2026
Elevance Health, Inc. has rebounded ~34% from its March lows, supported by sector recovery and improved Q1 2026 results. Q1 2026 saw ELV revenue up 1.5% to $49.5bn, adjusted EPS up 5.1% to $12.58, and
Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
06:46am, Wednesday, 27'th May 2026
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health is advancing its commitment to improving healthcare access by addressing one of healthcare's most pressing challenges: the digital divide. Through innova
Elevance Health (ELV) Up 12.6% Since Last Earnings Report: Can It Continue?
12:32pm, Friday, 22'nd May 2026
Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?
AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers
09:25am, Tuesday, 19'th May 2026
Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution.
Is ELV Undervalued? DCF Says Worth $643
07:49am, Tuesday, 19'th May 2026
On May 19, 2026, we present a detailed DCF analysis for Elevance Health Inc (ELV), a company currently trading at $394.07. The stock has shown a strong price pe
Elevance Health, Inc. (ELV) Shareholder/Analyst Call Prepared Remarks Transcript
09:50am, Wednesday, 13'th May 2026
Elevance Health, Inc. (ELV) Shareholder/Analyst Call Prepared Remarks Transcript
A Look at Elevance Health Inc (ELV) After 4.0% Gain -- GF Value $518.29 vs Price $393.30
07:01pm, Tuesday, 12'th May 2026
On May 12, 2026, Elevance Health Inc (ELV) shares rose 4.0% today, bringing the current price to $393.30. The stock has experienced a 52-week range between $273
